Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marc Kolkman is active.

Publication


Featured researches published by Marc Kolkman.


Applied and Environmental Microbiology | 2008

The Twin-Arginine Signal Peptide of Bacillus subtilis YwbN Can Direct either Tat- or Sec-Dependent Secretion of Different Cargo Proteins: Secretion of Active Subtilisin via the B. subtilis Tat Pathway

Marc Kolkman; René van der Ploeg; Michael Bertels; Maurits van Dijk; Joop van der Laan; Jan Maarten van Dijl; Eugenio Ferrari

ABSTRACT Proteins that are produced for commercial purposes in Bacillus subtilis are commonly secreted via the Sec pathway. Despite its high secretion capacity, the secretion of heterologous proteins via the Sec pathway is often unsuccessful. Alternative secretion routes, like the Tat pathway, are therefore of interest. Two parallel Tat pathways with distinct specificities have previously been discovered in B. subtilis. To explore the application potential of these Tat pathways, several commercially relevant or heterologous model proteins were fused to the signal peptides of the known B. subtilis Tat substrates YwbN and PhoD. Remarkably, the YwbN signal peptide directed secretion of active subtilisin, a typical Sec substrate, via the B. subtilis TatAyCy route. In contrast, the same signal peptide directed Tat-independent secretion of the Bacillus licheniformis α-amylase (AmyL). Moreover, the YwbN signal peptide directed secretion of SufI, an Escherichia coli Tat substrate, in a Tat-independent manner, most likely via Sec. Our results suggest that cytoplasmic protein folding prior to translocation is probably a major determinant of Tat-dependent protein secretion in B. subtilis, as is the case with E. coli. We conclude that future applications for the Tat system of B. subtilis will most likely involve commercially interesting proteins that are Sec incompatible.


Carbohydrate Polymers | 2018

Synthesis of fructooligosaccharides (FosA) and inulin (InuO) by GH68 fructosyltransferases from Bacillus agaradhaerens strain WDG185

Slavko Kralj; Chris Leeflang; Estefanía Ibáñez Sierra; Błażej Kempiński; Veli Alkan; Marc Kolkman

Fructooligosaccharides (FOS) and inulin, composed of β-2-1 linked fructose units, have a broad range of industrial applications. They are known to have various beneficial health effects and therefore have broad application potential in nutrition. For (modified) inulin also for non-food purposes more applications are arising. Examples are carboxymethylated inulin as anti-scalant and carboymlated inulin as emulsifiers. Various plants synthesize FOS and/or inulin type of fructans. However, isolating of FOS and inulin from plants is challenging due to for instance varying chains length. There is an increasing demand for FOS and inulin oligosaccharides and alternative procedures for their synthesis are attractive. We identified and characterized two fructosyltransferases from Bacillus agaradhaerens WDG185. FosA, a β-fructofuranosidase, synthesises short chain fructooligosaccharides (GF2-GF4) at high sucrose concentration, whereas InuO, an inulosucrase, synthesises a broad range of inulooligosaccharides (GF2-GF24) from sucrose, very similar to plant derived inulin. FosA and InuO showed activity over a broad pH range from 6 to 10 and optimal temperature at 60°C. Calcium ions and EDTA were found to have no effect on the activity of both enzymes. Kinetic analysis showed that only at relatively low substrate concentrations both enzymes showed Michaelis-Menten type of kinetics for total and transglycosylation activity. Both enzymes showed increased transglycosylation upon increasing substrate concentrations. These are the first examples of the molecular and biochemical characterization of a β-fructofuranosidase (FosA) and an inulosucrase enzyme (InuO) and its product from a Bacillus agaradhaerens strain.


Acta Crystallographica Section F-structural Biology and Crystallization Communications | 2007

Structure determination and analysis of a bacterial chymotrypsin from Cellulomonas bogoriensis.

Andrew Shaw; Mae Saldajeno; Marc Kolkman; Brian E. Jones; Richard R. Bott

The crystal structure of a secreted chymotrypsin from the alkaliphile Cellulomonas bogoriensis has been determined using data to 1.78 A resolution and refined to a crystallographic R factor of 0.167. The crystal structure reveals a large P1 substrate-specificity pocket, as expected for chymotrypsins. The structure is compared with close structural homologues. This comparison does not reveal clear reasons for the alkali tolerance of the enzyme, but the greater compactness of the structure and lowered hydrogen bonding may play a role.


Archive | 2004

Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same

Brian E. Jones; Marc Kolkman; Chris Leeflang; Hiroshi Oh; Ayrookaran J. Poulose; Eugene S. Sadlowski; Andrew Shaw; Der Kleij Wilhelmus A. H. Van; Marrewijk Leo Van


Archive | 2005

Mutant alpha-amylases

Eugenio Ferrari; Marc Kolkman; Craig E. Pilgrim


Archive | 2008

Variants of bacillus sp. TS-23 alpha-amylase with altered properties

Claudine Chang; Clement Choy; Melodie Estabrook; Mansi Goyal; Thomas P. Graycar; Victoria Huang; Brian E. Jones; Marc Kolkman; Karsten Matthias Kragh; Chris Leeflang; Scott D. Power; Sandra W. Ramer; Andrew Shaw; Casper Vroemen; Walter Weyler


Archive | 2006

Personal care compositions and methods for their use

Katherine D. Collier; Anthony G. Day; Nobel Hans De; David A. Estell; Grant Ganshaw; Marc Kolkman; Raj Lad; Jeffrey V. Miller; Christopher J. Murray; Scott D. Power; Brian Schmidt; Kimmenade Anita Van; Gudrun Vogtentanz


Proteomics | 2006

Proteomic dissection of potential signal recognition particle dependence in protein secretion by Bacillus subtilis

Geeske Zanen; Haike Antelmann; Rob Meima; Jan D. H. Jongbloed; Marc Kolkman; Michael Hecker; Jan Maarten van Dijl; Wim J. Quax


Archive | 2010

Compositions and methods comprising alpha-amylase variants with altered properties

David A. Estell; Brian E. Jones; Marc Kolkman; Christian D. Adams; Edward M. Concar


Microbiology | 2002

Organization and characterization of the capsule biosynthesis locus of Streptococcus pneumoniae serotype 9V

Saskia van Selm; Marc Kolkman; Bernard A.M. van der Zeijst; Kornelisje A. Zwaagstra; Wim Gaastra; Jos P. M. van Putten

Collaboration


Dive into the Marc Kolkman's collaboration.

Researchain Logo
Decentralizing Knowledge